Ann Marie Rogers won a landmark victory to make the breast cancer drug Herceptin more widely available. Here, she explains what drove her. But others are asking if the treatment really lives up to ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

While the pembrolizumab copy was eye-catching, the firm’s next big biosimilar launch in Europe is a version of Roche’s Herceptin (trastuzumab). Biosimilar companies are poised to launch ...

They were pleading for “access - not excuses” when it came to Genentech’s promising new treatment for metastatic breast cancer: a drug called trastuzumab, also known as Herceptin®.

Credit: Dr Khuloud T. Al-Jamal License: (CC BY 4.0) Guiding chemotherapy to a tumour by attaching it to the antibody-based target drug Herceptin (trastuzumab) is effective at treating women with ...

If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Herceptin SC? Herceptin SC contains the active ingredient trastuzumab. Herceptin SC is used to ...

HER2-positive breast cancers can be very aggressive. For several years, the drug Herceptin has been used to treat women with HER2-positive breast cancer that has metastasized or recurred.

High TILs may predict which patients with early HER2-positive breast cancer may have a reduced risk for disease relapse or death with Herceptin treatment. High tumor infiltrating lymphocytes (TILs) in ...

The Mumbai-based chemical generics manufacturer is taking aim at top-selling biologics—Roche's Avastin (bevacizumab) and Herceptin (trastuzumab) and Pfizer/Amgen's Enbrel (etanercept)—which ...

What Is HER2-Positive Breast Cancer? HER2-positive breast cancer is when breast cancer cells have a protein receptor called human epidermal growth factor receptor 2 (HER2). Normally, this protein ...

Herceptin SC administration reduces delivery time from ~30 minutes (with intravenous Herceptin) to ~5 minutes 1. • Rituxan Hycela (US)/MabThera SC (Europe) administration time was reduced from ...

The FDA’s decision for full approval will be made after more studies are completed. Enhertu and Herceptin are also used for HER2-positive stomach cancer. In addition, Enhertu is used for three ...